Atlas Trials

Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon Cancer

Clinical trial NCT00094809 · COMPLETED

Trial details

NCT number
NCT00094809
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colon CancerColorectal CancerRectal Cancer
Start date
2003-02-01
Primary completion
2006-05-19
Enrollment
252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.